Label: ADVANCED LIGHTNING- octinoxate and hydroquinone cream
-
Contains inactivated NDC Code(s)
NDC Code(s): 24623-042-22 - Packager: CBI Laboratories, Inc
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph not final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated January 5, 2011
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredient
- Purpose
- Uses
- Warnings
- Directions
-
Inactive ingredients
Aloe Barbadensis Leaf Juice, Ascorbyl Palmitate, Butylene Glycol, Cetyl Alcohol, Citric Acid, Coco-Caprylate/Caprate, Cucumis Sativus (Cucumber) Oil, DEA-Cetyl Phosphate, Diazolidinyl Urea, Dimethicone, Disodium EDTA, Ethylhexyl Methoxycinnamate, Glycerin, Hydrogenated Vegetable Oil, Hydroxyethylcellulose, Lavandula Angustifolia (Lavender) Oil, Magnesium Ascorbyl Phosphate, Methylparaben, Morus Bombycis Root Extract, Propylene Glycol, Propylparaben, Rosa Damascena Flower Water, Saxifraga Sarmentosa Extract, Scutellaria Baicalensis Root Extract, Sodium Bisulfite, Sodium PCA, Sodium Sulfite, Stearic Acid, Tocopherol, Tocopheryl Acetate, Vitis Vinifera (Grape) Fruit Extract, Water (Aqua)
- PRINCIPAL DISPLAY PANEL - 56.7 g Carton
-
INGREDIENTS AND APPEARANCE
ADVANCED LIGHTNING
octinoxate and hydroquinone creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:24623-042 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 0.02 g in 1 g HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE) HYDROQUINONE 0.02 g in 1 g Inactive Ingredients Ingredient Name Strength GLYCERIN (UNII: PDC6A3C0OX) ALOE VERA LEAF (UNII: ZY81Z83H0X) CETYL ALCOHOL (UNII: 936JST6JCN) DIETHANOLAMINE CETYL PHOSPHATE (UNII: 4UG0316V9S) WATER (UNII: 059QF0KO0R) DIMETHICONE 350 (UNII: 2Y53S6ATLU) SODIUM SULFITE (UNII: VTK01UQK3G) DIAZOLIDINYL UREA (UNII: H5RIZ3MPW4) ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) STEARIC ACID (UNII: 4ELV7Z65AP) ASCORBYL PALMITATE (UNII: QN83US2B0N) SODIUM METABISULFITE (UNII: 4VON5FNS3C) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) EDETATE DISODIUM (UNII: 7FLD91C86K) SODIUM PYRROLIDONE CARBOXYLATE (UNII: 469OTG57A2) CUCUMBER (UNII: YY7C30VXJT) MAGNESIUM ASCORBYL PHOSPHATE (UNII: 0R822556M5) ROSA DAMASCENA FLOWER OIL (UNII: 18920M3T13) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:24623-042-22 56.7 g in 1 JAR Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 07/01/2005 Labeler - CBI Laboratories, Inc (623704368) Establishment Name Address ID/FEI Business Operations CBI Laboratories, Inc. 623704368 MANUFACTURE